Obesity continues to rise in the United States, with significant implications for metabolic health. One common way to assess body weight status is Body Mass Index (BMI), which is calculated as weight in kilograms divided by height in meters squared (kg/m²).

  • A BMI over 25 is considered overweight

  • A BMI over 30 is considered obese

Between 1976 and 2002, the number of overweight American adults increased by approximately 38%, while the number of obese adults doubled. About half of all American adults are overweight, and approximately 25% of Americans under the age of 40 are obese.

Childhood Obesity: A Growing Concern

Trends in children are particularly concerning. Between 1963 and 1970, only:

  • 4% of children ages 6–11

  • 5% of adolescents ages 12–19

were classified as overweight.

By 1999–2002, the prevalence in both age groups had risen to 16%, representing more than a threefold increase.

According to research published in the New England Journal of Medicine (Yale University study, March 14, 2002):

  • Approximately 20% of American children are overweight

  • 25% of children aged 4–10 and 21% of those aged 11–18 show early signs of type 2 diabetes, demonstrated by impaired glucose tolerance

  • Younger children appear to be affected more severely than older adolescents

Type 1 vs. Type 2 Diabetes: Key Differences

Type 1 Diabetes

Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, with autoantibodies present in approximately 80% of cases. Patients are typically lean, and without insulin therapy they are prone to ketoacidosis, a condition in which fat is burned for fuel because glucose cannot be adequately utilized. This process produces ketones.

Clinical features include:

  • Glucosuria (glucose in the urine once blood glucose exceeds renal reabsorption capacity, ~165 mg/dL)

  • Polyuria and polydipsia (frequent urination and excessive thirst)

  • Electrolyte loss due to glucose acting as an osmotic diuretic

Type 2 Diabetes

Type 2 diabetes results from insulin resistance, sometimes referred to as Syndrome X. Unlike individuals with type 1 diabetes, people with type 2 diabetes are typically overweight and produce adequate—or even excessive—amounts of insulin, but their cells respond poorly to it.

Diagnostic criteria include:

  • Fasting blood glucose over 140 mg/dL on two occasions

  • Blood glucose over 200 mg/dL during a glucose tolerance test

  • Blood glucose between 140–180 mg/dL during a glucose tolerance test is considered impaired glucose tolerance

Type 2 diabetes usually develops after age 40, although this pattern is changing. Ketoacidosis is rare.

Insulin: A Central Metabolic Hormone

Insulin is an anabolic hormone involved in fuel storage and tissue building. When insulin binds to receptors on cell membranes, approximately 80% of the body’s cells become permeable to glucose.

Once inside the cell:

  • Glucose is phosphorylated and used for energy

  • Excess glucose is stored as glycogen

  • Surplus glucose is converted into triglycerides and stored as fat

In the presence of high insulin levels, fat burning is suppressed and fat storage is promoted.

Insulin also:

  • Enhances amino acid uptake

  • Increases protein synthesis

  • Decreases protein breakdown

Insulin deficiency or resistance therefore leads to increased protein catabolism, releasing amino acids that serve as substrates for gluconeogenesis.

Insulin has a half-life of 30–45 minutes and is cleared within about 6 hours, though cellular effects may persist longer. Insulin is broken down by insulinase, a zinc-dependent enzyme in the liver and kidneys.

Glucose Handling and Fat Storage

Approximately 60% of dietary glucose is stored in the liver as glycogen. Once liver storage capacity is exceeded, glucose is converted into fatty acids, packaged as triglycerides in VLDL, and deposited as fat.

Insulin inhibits gluconeogenesis by:

  • Reducing enzyme activity

  • Decreasing the release of amino acids needed for glucose production

Chronic Hyperglycemia and Complications

Persistently elevated glucose leads to glycosylation of proteins, including:

  • Hemoglobin (HbA1c)

  • Collagen

  • Myelin

  • Lens proteins

  • Muscle proteins

Early glycosylation changes may be reversible, but over time they contribute to the formation of advanced glycation end products (AGEs).

Major complications include:

  • Neuropathy: Peripheral loss of sensation and proprioception

  • Retinopathy: Microvascular damage to the eye, including proliferative retinopathy

  • Nephropathy: Proteinuria, nephrotic syndrome, hypertension

  • Infections: Impaired immune function

  • Cardiovascular disease: The leading cause of death in diabetes, accounting for ~65% of mortality

Importantly, cardiovascular risk often precedes the diagnosis of type 2 diabetes by many years.

The Sorbitol Pathway and Cellular Damage

In tissues such as the eyes, kidneys, and nerves, glucose enters cells without insulin and is converted to sorbitol and then fructose. Sorbitol accumulation causes:

  • Osmotic stress

  • Cellular swelling

  • Electrolyte imbalance

  • Depletion of glutathione, nitric oxide, inositol, and taurine

This pathway is driven by the enzyme aldose reductase.

Gluconeogenesis, Stress, and Muscle Loss

Gluconeogenesis is the production of glucose from non-carbohydrate sources such as amino acids, lactate, glycerol, and pyruvate. While insulin suppresses gluconeogenesis, stress-induced cortisol and intracellular glucose deficiency increase it.

Insulin resistance creates a functional deficiency of both insulin and glucose inside cells, contributing to:

  • Loss of lean muscle mass

  • Increased fat accumulation

Glucose Transporters (GLUT)

Glucose transport into cells depends on GLUT transporters:

  • GLUT1: most tissues

  • GLUT2: liver and pancreatic beta cells

  • GLUT3: brain

  • GLUT4: muscle, heart, adipose tissue

Defects in GLUT4 function are thought to play a central role in insulin resistance.

Common Features of Insulin Resistance

Individuals with insulin resistance often experience:

  • Fatigue

  • Weight gain and difficulty losing weight

  • Brain fog and poor concentration

  • Carbohydrate cravings

  • Reactive hypoglycemia after high-carbohydrate meals

  • Mood changes or depression

Sugar Consumption: A Historical Perspective

Modern diets include over 150 pounds of sugar per person per year. By comparison:

  • Around 1900: ~75 pounds/year

  • Britain in 1750: ~7.5 pounds/year

These shifts parallel the rise in obesity, insulin resistance, and type 2 diabetes.